MARK W SHEN
Allopathic & Osteopathic Physicians|Family Medicine OSAGE BEACH, MO NPI 1265401285
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine MO Amgen Inc. All categories
General Payments — all program years on this page
$10,339.13
- Category: General Payments
- Program years: PY2018–2024
- Record count: 576
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,274.13 across 71 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,274.13 | 71 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $186.23 | 13 |
| Novo Nordisk AS | $151.44 | 9 |
| Abbott Laboratories | $117.08 | 7 |
| Medtronic, Inc. | $83.87 | 3 |
| Lilly USA, LLC | $77.64 | 4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $76.05 | 4 |
| GlaxoSmithKline, LLC. | $46.69 | 3 |
| IRONWOOD PHARMACEUTICALS, INC | $45.02 | 2 |
| Xeris Pharmaceuticals, Inc. | $43.32 | 2 |
| Phathom Pharmaceuticals, Inc. | $42.80 | 3 |
| ABBVIE INC. | $41.51 | 2 |
| Acerta Pharma LLC | $41.43 | 2 |
| Kyowa Kirin, Inc. | $39.55 | 2 |
| Merck Sharp & Dohme Corporation | $38.20 | 2 |
| Sumitomo Pharma America, Inc. | $33.74 | 2 |
| PFIZER INC. | $30.74 | 2 |
| Astellas Pharma US Inc | $28.40 | 1 |
| SANOFI PASTEUR INC. | $27.33 | 1 |
| Mylan Specialty L.P. | $22.29 | 1 |
| SHIELD THERAPEUTICS INC | $18.09 | 1 |
| Teva Pharmaceuticals USA, Inc. | $17.44 | 1 |
| Lundbeck LLC | $17.24 | 1 |
| Neurelis, Inc. | $17.24 | 1 |
| Otsuka America Pharmaceutical, Inc. | $16.94 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $13.85 | 1 |
By program year
Records — PY2024 (71)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.